1. Academic Validation
  2. Deletion of the plexin-D1 ectodomain leads to anoikis by suppressing integrin inside-out signaling

Deletion of the plexin-D1 ectodomain leads to anoikis by suppressing integrin inside-out signaling

  • Mol Biol Cell. 2025 Jun 1;36(6):ar71. doi: 10.1091/mbc.E25-02-0075.
Toshihiko Toyofuku 1 Takako Ishikawa 1 Atsushi Kumanogoh 2 3 4
Affiliations

Affiliations

  • 1 Department of Immunology and Molecular Medicine, Graduate School of Medicine, The Center of Medical Innovation and Translational Research, Osaka University, Suita, Osaka 565-0871, Japan.
  • 2 Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
  • 3 Laboratory of Immunopathology, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
  • 4 Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka 565-0871, Japan.
Abstract

Plexin-D1, mainly expressed in endothelial and Cancer cells, regulates diverse effects, suppresses endothelial cell growth, and induces Cancer cell migration and proliferation. Here, we demonstrated that plexin-D1 was cleaved by proteinase on Cancer cells. To examine the role of cleaved plexin-D1 in cells, Madin-Darby canine kidney (MDCK) cells overexpressing truncated plexin-D1 were cultured in Matrigel. MDCK cells expressing plexin-D1 lacking the ectodomain (plexin-D1 ΔEC) underwent Apoptosis. An adhesion assay for extracellular matrix (ECM) molecules showed that plexin-D1 ΔEC-expressing MDCK cells lost their affinity for the ECM. These results suggest that plexin-D1 ΔEC blocks Integrin inside-out signaling, leading to detachment from the ECM and Apoptosis, so-called anoikis. By contrast, MDCK cells expressing full-length plexin-D1 or plexin-D1 lacking the cytoplasmic domain (plexin-D1 ΔIC) developed multicellular branching tubular structures in Matrigel. This morphological change was blocked in plexin-D1-expressing MDCK cells by the hepatocyte growth factor receptor (Met) loss of function or by Met inhibitors. These results suggest that plexin-D1 associates with Met through the plexin-D1 extracellular domain, and this activates Met cytoplasmic kinase activity. We therefore conclude that plexin-D1 contains distinct domains that determine the fate of Cancer cells.

Figures
Products